Keyur Patel

Original Research

Safety and Efficacy of an Autologous Blood Clot Product in the Management of Texas 1A or 2A Neuropathic Diabetic Foot Ulcers: A Prospective, Multicenter, Open Label Pilot Study

07/02/2018

Keyur Patel ;

Maria A. Kasper ;

Igal Kushnir ;

Marissa J. Carter , PhD;

Robert J. Snyder , MD, PhD, DPM, FACFAS, CWS-P, MBA;

Thomas E. Serena , MD, FACS, FACHM, MAPWCA;

Alon Kushnir ;

This pilot study evaluates safety in terms of the occurrence of adverse events (AEs) as well as the efficacy in terms of complete wound healing rates of a blood clot product when applied to chronic neuropathic diabetic foot ulcers (DFUs).

This pilot study evaluates...

07/02/2018

Wounds

Hypothermically Stored Human Amniotic Membrane (HSAM) for the Management of Diabetic Foot Ulcers

Abstract Body: Objective: Diabetic foot ulcers (DFUs) continue to challenge wound care practitioners. They are prone to infection and increase the risk of lower extremity amputation. The ...

Stacey Coe , BA, CCRP, CRC;

Michael Leon Sabolinski , MD;

Sarah Moore , SC;

Keyur Patel ;

Windy E. Cole , DPM, CWSP, FACCWS;

Bryan Doner ;

Santina Wendling ;

Rachel Hamil ;

Raphael Yaakov ;

11/23/2020

The Use of Autologous Blood Clot in a Management of Chronic Wounds in a Specialized Nursing Facility (SNF)

Background: The RD1 product (RedDress Ltd.), cleared by the FDA in July 2018 for creating autologous blood clots for management of cutaneous wounds, is investigated in a SNF setting as pa...

Keyur Patel ;

Thomas E. Serena , MD, FACS, FACHM, MAPWCA;

11/20/2019

Analysis of Three Prospective Open-Label Clinical Trials with Autologous Blood Clot in Chronic Wounds

Background: The RD1 (RedDress Ltd.) was cleared by the FDA in July 2018 for creating autologous blood clots for management of cutaneous wounds, and was the subject of three prospective st...

Keyur Patel ;

Thomas E. Serena , MD, FACS, FACHM, MAPWCA;

11/20/2019

Wound Assessment Paradigm Shift: A 350-Patient Multi-Site Clinical Trial Incorporating Bacterial Fluorescence Imaging into Standard of Care

Objective: Moderate-to-heavy bacterial loads delay healing and can lead to infection; therefore, clinical evaluation of signs and symptoms (CSS) of the bacterial-infection continuum is im...

Laura Serena ;

Thomas E. Serena , MD, FACS, FACHM, MAPWCA;

Matthew Sabo , DPM;

Lam Le , MD;

Gabriel Halperin ;

Rachel Hamil ;

Khristina Harrell ;

Kerry T. Thibodeaux , MD;

Patrick Briggs ;

Keyur Patel ;

Marc Baer ;

Maria A. Kasper ;

Neal Bullock ;

Windy E. Cole , DPM, CWSP, FACCWS;

Daniel DiMarco ;

Eliabeth Clapp ;

10/25/2019

How Little We Know About Wound Bacterial Burden

Introduction: Wound colonization and infection are often asymptomatic and are therefore grossly under-detected in the chronic wound population. Typically polymicrobial in nature, the vast...

Laura Serena ;

Matthew Sabo , DPM;

Gabriel Halperin ;

Khristina Harrell ;

Patrick Briggs ;

Marc Baer ;

Neal Bullock ;

Daniel DiMarco ;

Thomas E. Serena , MD, FACS, FACHM, MAPWCA;

Eliabeth Clapp ;

Lam Le , MD;

Rachel Hamil ;

Kerry T. Thibodeaux , MD;

Keyur Patel ;

Maria A. Kasper ;

Windy E. Cole , DPM, CWSP, FACCWS;

Raphael Yaakov ;

10/25/2019

Meta Analysis of 3 Prospective, Open-Label, Studies with Autologous Blood Clot in Chronic Wounds

Background: The RD1 product (RedDress Ltd.) which was cleared by FDA in July 2018, for creating autologous blood clots for management of cutaneous wounds, was the subject of 3 prospective...

Thomas E. Serena , MD, FACS, FACHM, MAPWCA;

Keyur Patel ;

08/19/2019

The Use of Autologous Blood Clot in Management of Chronic Wounds in Specialized Nursing Facility (SNF)

Background: The RD1 product (RedDress Ltd.) which was cleared by FDA in July 2018, for creating autologous blood clots for management of cutaneous wounds, is investigated in a SNF setting...

Thomas E. Serena , MD, FACS, FACHM, MAPWCA;

Keyur Patel ;

08/19/2019

Bacterial Fluorescence Image Guidance of Antimicrobial Decision Making and Stewardship

Objective: Targeted, appropriate antimicrobials can prevent escalation to infection and future antibiotic necessity. Antimicrobial misuse often stems from diagnostic uncertainty duri...

Khristina Serena ;

Matthew Sabo , DPM;

Gabriel Halperin ;

Thomas E. Serena , MD, FACS, FACHM, MAPWCA;

Monique Y. Rennie , PhD;

Lam Le , MD;

Keyur Patel ;

Raphael Yaakov ;

08/19/2019

Bacterial Fluorescence Imaging Guides Wound Assessment, Wound Bed Preparation, and Treatment Plan in a Multisite Clinical Trial

Objective: Wound assessment is paramount for understanding the wound bioburden and the decisions a clinician must make re: wound bed preparation and treatment plan. Point-of-care fluoresc...

Thomas E. Serena , MD, FACS, FACHM, MAPWCA;

Lam Le , MD;

Keyur Patel ;

Windy E. Cole , DPM, CWSP, FACCWS;

Laura Serena ;

Khristina Serena ;

Matthew Sabo , DPM;

Gabriel Halperin ;

08/13/2019